Honestamente, el panorama empresarial actual está cambiando a una velocidad que a veces asusta un poco. No se trata de una evolución lenta ni de cambios superficiales que se puedan ignorar. La llegada de la inteligencia artificial ha modificado las reglas del juego de una manera tan pr …
Cómo la Inteligencia Artificial Está Transformando a las Empresas Modernas Read More »
Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.
Medtech M&A maintains momentum following decade-high 2025: PwC Read More »
The shortage follows Hologic removing certain breast biopsy needles from the market in January.
FDA warns breast biopsy needle shortage to continue into 2027 Read More »
After a regulatory odyssey that delayed a filing for what would be the first genetic medicine for Huntington’s disease, the FDA has agreed that three-year data from uniQure’s Phase 1/2 trial are sufficient to support an accelerated biologics license application.
The average number of issuers fell from a record high of 9.6 per state in 2025 to just nine this year, according to the health policy research group.
Fewer insurers participating in ACA marketplaces amid policy turmoil, KFF finds Read More »
Jazz Pharmaceuticals is diversifying its oncology strategy, orchestrating a new antibody deal with AbCellera that offers $56 million upfront, plus $792 million in biobucks for each of the three initial programs.
Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B Read More »
MMI built a robot to help surgeons perform microsurgical procedures with more control than is possible with the human hand alone.
‘Putting the body back together’ with MMI’s microsurgery robot Read More »
After a regulatory odyssey that delayed a filing for what would be the first genetic medicine for Huntington’s disease, the FDA has agreed that three-year data from uniQure’s Phase 1/2 trial are sufficient to support an accelerated biologics license application.
UniQure plans resubmission for Huntington’s gene therapy after FDA reverses course—again Read More »
El 8 de junio de 2026, la sonda espacial Parker de la NASA, que partió de la Tierra en 2018, alcanzó la mínima distancia al Sol en su nuevo sobrevuelo de este. Llegó a acercarse a él hasta una distancia de apenas 6,2 millones de kilómetros, igualando el r&ea …
Sobrevuelo número 28 del Sol por la sonda espacial Parker Read More »
El pasado 12 de junio, el avión experimental X-59 de la NASA voló por vez primera a una velocidad de Mach 1,4 (unos 1500 kilómetros por hora) y llegó hasta una altitud de casi 17 kilómetros. Al cruzar la barrera del sonido, los aviones supersónicos …
El revolucionario avión silencioso X-59 vuela más rápido y alto que nunca antes Read More »
